CAPR

CAPR

USD

Capricor Therapeutics Inc. Common Stock

$6.060+0.005 (0.083%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$6.055

Haut

$6.410

Bas

$6.000

Volume

0.58M

Fondamentaux de l'Entreprise

Capitalisation Boursière

277.0M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.33M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $5.68Actuel $6.060Haut $20.75

Actualités Connexes

GlobeNewswire

Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel

–Publication highlights Deramiocel's anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, 2025 (GLOBE

Voir plus
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
GlobeNewswire

Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10

SAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today

Voir plus
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
PR Newswire

Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ:...

Voir plus
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.